C2N Diagnostics, LLC (“C2N”), which provides exceptional clinical laboratory services and advanced diagnostic solutions in the field of brain health, has entered into a non-exclusive agreement with Mayo Clinic Laboratories, for inclusion of C2N’s Precivity tests in Mayo Clinic Laboratories’ test offerings to its clients.
Merck, a leading science and technology company, and The Michael J. Fox Foundation for Parkinson's Research (MJFF), are advancing research aimed at slowing progression of Parkinson’s disease (PD).
Cole-Parmer, an Antylia Scientific company, is pleased to reintroduce peristaltic pumps to enhance its industry-leading line of fluid handling solutions.
To support the future implementation of workflow automation in cell therapy production, Thermo Fisher Scientific introduces the Thermo Scientific™ Heracell™ VIOS™ 250i AxD CO2 Incubators.
Thermo Fisher Scientific Inc. the world leader in serving science, today unveiled the Thermo Scientific™ Stellar™ mass spectrometer (MS), a new solution that combines fast throughput, high sensitivity, and ease of use to allow researchers to advance their translational omics research and make breakthrough discoveries more efficiently.
A June 11 online auction by Tiger Group and Liquidity Services features intellectual property and $12 million in medical equipment and inventory from Medrobotics including 23 of the company's groundbreaking Flex and next-gen Flex360 surgical robotics systems.
Terumo Blood and Cell Technologies a medical technology company, recently received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Rika Plasma Donation System™ with the iNomi™ Nomogram. This innovation means that plasma collection volume can be determined by an individual donor's height, weight and hematocrit level on the day they donate plasma.
ONFAB, a leading European provider of single-use, flexible containment solutions for the pharmaceutical industry, has officially business operations in the United States in conjunction with parent company Savillex.
Generating cutting-edge therapeutics requires precision, safety, and efficiency from manufacturing equipment. The next generation of oligo manufacturing, the process of producing short sequences of nucleotides (building blocks of DNA or RNA), innovation from Asahi Kasei Bioprocess (AKB).
QuidelOrtho Corporation (Nasdaq: QDEL) has added the ARK™ Fentanyl II Assay to its U.S. Vitros® XT 7600 and 5600 Integrated Systems as well as its Vitros® 4600 Chemistry System menu of assays as a MicroTip® Partnership Assay (“MPA”).